ERAS in Patients With Perforated Peptic Ulcer Disease Who Underwent Laparoscopic Repair

Hospital Stay Clinical Trial

Official title: Enhanced Recovery After Surgery in Patients With Perforated Peptic Ulcer Disease Who Underwent Laparoscopic Repair, a Randomised Controlled Clinical Trial

Status Recruiting

Clinical Trial Summary

Perforated peptic ulcer (PPU) is a frequent emergency condition worldwide with associated mortality up to 30%. Open procedures have in the most part been replaced by laparoscopic techniques. The standard postoperative management of PPUD patients is predominantly based on traditional practices. The aim of this randomized controlled clinical trial was to investigate the feasibility of enhanced postoperative recovery pathways in patients who underwent laparoscopic repair for Perforated peptic ulcer.

Clinical Trial Description

Perforated peptic ulcer (PPU) is a frequent emergency condition worldwide with associated mortality up to 30%. Open procedures have in the most part been replaced by laparoscopic techniques. The standard postoperative management of PPUD patients is predominantly based on traditional practices. Randomization will be made at the end of the surgical procedure. Patients will be included in groups 1 or2. Group 1 is the control group and will receive standard postoperative care, and group 2 is the ERAS group.The aim of this randomized controlled clinical trial was to investigate the feasibility of ERAS in patients who underwent laparoscopic repair for Perforated peptic ulcer. ;

Related Conditions & MeSH terms

• Hospital Cost
• Hospital Stay
• Peptic Ulcer
• Peptic Ulcer Perforation

• NCT number: NCT04039646
• Study type: Interventional
• Source: Beijing Chao Yang Hospital
• Contact: Jia Gang Han, MD
• Phone: +86013522867841
• Email: hjg211@163.com
• Status: Recruiting
• Phase: N/A
• Start date: July 1, 2019
• Completion date: March 31, 2022